Self-reported treatment adherence in inflammatory bowel disease in Indian patients

Indian Journal of Gastroenterology

Volumn 28, Issue 4, 2009, Pages 143-146

  Bhatt, Jay ^a   Patil, Samir ^a   Joshi, Anand ^a   Abraham, Philip ^a   Desai, Devendra ^a  

^a P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

Crohn1s disease; Glucocorticoids; Immunosuppressive agents; Mesalamine; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; BIOLOGICAL FACTOR; MESALAZINE; ANTIINFLAMMATORY AGENT; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE COURSE; DISEASE DURATION; DISEASE SURVEILLANCE; ENTERITIS; FEMALE; HISTOLOGY; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; QUESTIONNAIRE; RECURRENT DISEASE; SELF REPORT; ULCERATIVE COLITIS; CROSS-SECTIONAL STUDY; INDIA; PATHOLOGY;

ADULT; ANTI-INFLAMMATORY AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INDIA; INFLAMMATORY BOWEL DISEASES; MALE; MEDICATION ADHERENCE; QUESTIONNAIRES;

EID: 77954662084     PISSN: 02548860     EISSN: 02548860     Source Type: Journal    
DOI: 10.1007/s12664-009-0050-z     Document Type: Article

References (18)

1. Kane S, Huo D, Aikens J, Hanauer S. Medication non-adherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med 2003;114:39-43.
2. Kane SV, Brixner D, Rubin DT, Sewitch MJ. The challenge of compliance and persistence: focus on ulcerative colitis. J Manag Care Pharm 2008;14:s2-12.
3. Pasternak R. Report of the Adult Treatment Panel III: the 2001 National Cholesterol Education Program guidelines on the detection, evaluation and treatment of elevated cholesterol in adults. Cardiol Clin 2003;21:393-8.
4. Weiss JJ, Bhatti L, Dieterich DT, et al. Hepatitis C patients' self-reported adherence to pegylated interferon and ribavirin. Aliment Pharmacol Ther 2008;28:289-93
5. Sewitch MJ, Abrahamowicz M, Barkun A, et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol 2003;98:1535-44.
6. Lopez San Roman A, Bermejo F, Carrera E, Perez-Abad M, Boixeda D. Adherence to treatment in inflammatory bowel disease. Rev Esp Enferm Dig 2005;97:249-57.
7. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97.
8. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med 2007;167: 540-50.
9. D'Inca R, Bertomoro P, Mazzocco K, Vettorato MG, Rumiati R, Sturniolo GC. Risk factors for non-adherence to medication in inflammatory bowel disease patients. Aliment Pharmacol Ther 2008;27:166-72.
10. Hawthorne AB, Rubin G, Ghosh S. Review article: Medication non-adherence in ulcerative colitis-strategies to improve adherence with mesalazine and other maintenance therapies. Aliment Pharmacol Ther 2008; 27:1157-66.
11. Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol 2007;102:1417-26.
12. Dewulf Nde L, Monteiro RA, Passos AD, Vieira EM, Troncon LE. Compliance to drug therapy in inflammatory bowel diseases outpatients from a university hospital. Arq Gastroenterol 2007;44:289-96.
13. Farup PG, Hovde O, Halvorsen FA, Raknerud N, Brodin U. Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. A comparison of the efficacy and practicality of two topical treatment regimens. Scand J Gastroenterol 1995;30:164-70.
14. Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm 2006;12:239-45.
15. van der Wal MH, Jaarsma T, van Veldhuisen DJ. Non-compliance in patients with heart failure; how can we manage it? Eur J Heart Fail 2005;7:5-17.
16. Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther 2003;25: 2958-71.
17. van Hees PA, van Tongeren JH. Compliance to therapy in patients on a maintenance dose of sulfasalazine. J Clin Gastroenterol 1982;4:333-6.
18. Loftus EV Jr. A practical perspective on ulcerative colitis: patients' needs from aminosalicylate therapies. Inflamm Bowel Dis 2006;12:1107-13.